全文获取类型
收费全文 | 4768篇 |
免费 | 453篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 139篇 |
儿科学 | 121篇 |
妇产科学 | 141篇 |
基础医学 | 681篇 |
口腔科学 | 100篇 |
临床医学 | 557篇 |
内科学 | 811篇 |
皮肤病学 | 42篇 |
神经病学 | 347篇 |
特种医学 | 295篇 |
外国民族医学 | 5篇 |
外科学 | 673篇 |
综合类 | 114篇 |
一般理论 | 3篇 |
预防医学 | 480篇 |
眼科学 | 130篇 |
药学 | 352篇 |
中国医学 | 3篇 |
肿瘤学 | 228篇 |
出版年
2023年 | 50篇 |
2022年 | 40篇 |
2021年 | 81篇 |
2020年 | 74篇 |
2019年 | 102篇 |
2018年 | 116篇 |
2017年 | 82篇 |
2016年 | 90篇 |
2015年 | 94篇 |
2014年 | 124篇 |
2013年 | 194篇 |
2012年 | 279篇 |
2011年 | 271篇 |
2010年 | 126篇 |
2009年 | 127篇 |
2008年 | 224篇 |
2007年 | 187篇 |
2006年 | 202篇 |
2005年 | 219篇 |
2004年 | 213篇 |
2003年 | 179篇 |
2002年 | 194篇 |
2001年 | 113篇 |
2000年 | 127篇 |
1999年 | 99篇 |
1998年 | 48篇 |
1997年 | 40篇 |
1996年 | 49篇 |
1995年 | 52篇 |
1994年 | 42篇 |
1993年 | 46篇 |
1992年 | 131篇 |
1991年 | 94篇 |
1990年 | 81篇 |
1989年 | 87篇 |
1988年 | 67篇 |
1987年 | 76篇 |
1986年 | 67篇 |
1985年 | 72篇 |
1984年 | 57篇 |
1983年 | 54篇 |
1981年 | 25篇 |
1980年 | 28篇 |
1979年 | 28篇 |
1978年 | 35篇 |
1977年 | 27篇 |
1976年 | 28篇 |
1974年 | 41篇 |
1973年 | 34篇 |
1972年 | 25篇 |
排序方式: 共有5222条查询结果,搜索用时 250 毫秒
41.
42.
Corticosteroids for the Enhancement of Fetal Lung Maturity: Impact on the Gravida with Preeclampsia and the HELLP Syndrome 总被引:1,自引:0,他引:1
Everett F. Magann MD Rick W. Martin MD John D. Isaacs MD Pamela G. Blake RN MSN John C. Morrison MD James N. Martin Jr MD 《The Australian & New Zealand journal of obstetrics & gynaecology》1993,33(2):127-131
Summary: This study was undertaken to determine maternal impact of corticosteroids administered for the promotion of fetal lung maturity in mothers with the HELLP syndrome. Twenty-seven of 427 women with the HELLP syndrome treated between 1980–1991 received a full course of steroids prior to preterm delivery. This group was compared to 27 matched control patients with the HELLP syndrome who received no corticosteroids. Subjects were matched for maternal age, race, sex of the fetus, and severity of the HELLP syndrome. The antepartum platelet count stabilized or increased in 25 of 27 steroid-treated women in contrast to 0 of 15 control women (p <0.00001). In comparison to control patients, LDH serum concentrations in steroid-treated patients stabilized or decreased and the SGOT/AST and SGPT/ALT stabilized or decreased during therapy (p < 0.005). The interval from delivery to platelet nadir in patients with Class III HELLP syndrome was shorter in the steroid-treated group (p<0.008) than in untreated patients. 相似文献
43.
K. D. Blake S. Madden B. W. Taylor L. Rees 《Pediatric nephrology (Berlin, Germany)》1996,10(6):693-695
.A sedation regimen using sequential oral trinepazine, intravenous Pethco (pethidine, chlorpromazine and promethazine) and
diazemuls was evaluated in children having native kidney (n = 17) and transplant kidney (n = 17) biopsies. Biopsy was successful in all cases, with no serious side effects. A self-reported scale of memory recall
and pain perception showed the optimal time for biopsy to be between 30 and 90 min after the intravenous Pethco. The child’s
level of distress was measured by a self-reported scale, a parent-reported scale and an observational scale for doctors and
nurses; 45% of children rated themselves highly distressed prior to the procedure, their parents being the best assessors
of this distress. Younger children and those undergoing native kidney biopsy had less understanding of the procedure. Children’s
worries could be clearly categorised into procedural and outcome issues: those undergoing transplant biopsy were more worried
about outcome, whereas those undergoing native kidney biopsy were more worried about the procedure.
Received April 3, 1995; received in revised form and accepted April 17, 1996 相似文献
44.
Steven Mlynarek Morton Corn Charles Blake 《Regulatory toxicology and pharmacology : RTP》1996,23(3):213-224
The exposures of building maintenance personnel and occupants to airborne asbestos fibers, and the effects of operations and maintenance programs on those exposures, continue to be an important public health issue. The subject of this investigation was a large metropolitan county with numerous public buildings which routinely conducted air sampling for asbestos. A total of 302 personal air samples in nine task categories collected during maintenance worker activities in proximity to asbestos-containing materials were analyzed; 102 environmental air samples in four task categories were also analyzed. The arithmetic means of the 8-hr time weighted average exposures for personal sampling for each task category were all below the Occupational Safety and Health Administration permissible exposure level of 0.1 fibers (f)/cc > 5 μm. The highest mean 8-hr time weighted average exposure was 0.030 f/cc > 5 μm for ceiling tile replacement. The maximum asbestos concentration during sample collection for environmental samples was 0.027 f/cc > 5 μm. All asbestos-related maintenance work was done within the framework of an Operations and Maintenance Program (OMP) which utilized both personal protective equipment and controls against fiber release/dispersion. Results are presented in association with specific OMP procedures or controls. These results support the effectiveness of using Operations and Maintenance Programs to manage asbestos in buildings without incurring unacceptable risk to maintenance workers performing maintenance tasks. 相似文献
45.
Stereoscopic depth perception is possible when the short wave sensitive (SWS or "Blue") cones are isolated using a yellow adapting field. We have measured the maximum disparity that can be fused (the diplopia threshold) as a function of the separation between pairs of dots or lines. Under all conditions, these diplopia thresholds are the same for the isolated SWS cones as for the entire visual system. In addition, SWS diplopia thresholds vary as a linear function of dot or line separation, so that they exhibit disparity scaling. Further experiments show that disparity scaling is dependent upon the presence of low spatial frequencies in the stimulus and not upon the retinal eccentricity of stimulation. These data indicate that the SWS cones provide information to the disparity processing system through more than one low spatial frequency channel but not through high frequency ones. 相似文献
46.
47.
This review was designed to determine from the best evidence whether there is an association between postmenopausal hormonal treatment and breast cancer risk. Also, if there is an association, does it vary according to duration and cessation of use, type of regimen, type of hormonal product or route of administration; whether there is a differential effect on risk of lobular and ductal cancer; and whether hormone treatment is associated with breast cancers that have better prognostic factors? Data sources for the review included Medline, the Cochrane Database of Systematic Reviews (Cochrane Library, 2005) and reference lists in the identified citations. Eligible citations addressed invasive breast cancer risk among postmenopausal women and involved use of the estrogen products with or without progestin that are used as treatment for menopausal symptoms. Abstracted data were demographic groupings, categories of hormone use, categories of breast cancer, two-by-two tables of exposure and outcome and adjusted odds ratios, relative risks (RRs) or hazard rates. Average estimates of risk were weighted by the inverse variance method, or if heterogeneous, using a random effects model. The average risk of invasive breast cancer with estrogen use was 0.79 [95% confidence interval (95% CI) = 0.61-1.02] in four randomized trials involving 12 643 women. The average breast cancer risk with estrogen-progestin use was 1.24 (95% CI = 1.03-1.50) in four randomized trials involving 19 756 women. The average risks reported in recent epidemiological studies were higher: 1.18 (95% CI = 1.01-1.38) with current use of estrogen alone and 1.70 (95% CI = 1.36-2.17) with current use of estrogen-progestin. The association of breast cancer with current use was stronger than the association with ever use, which includes past use. For past use, the increased breast cancer risk diminished soon after discontinuing hormones and normalized within 5 years. Reasonably adequate data do not show that breast cancer risk varies significantly with different types of estrogen or progestin preparations, lower dosages or different routes of administration, although there is a small difference between sequential and continuous progestin regimens. Epidemiological studies indicate that estrogen-progestin use increases risk of lobular more than ductal breast cancer, but the number of studies and cases of lobular cancer remains limited. Among important prognostic factors, the stage and grade in breast cancers associated with hormone use [corrected] do not differ significantly from those in non-users, but breast cancers in estrogen-progestin users are significantly more likely to be estrogen receptor (ER) positive. In conclusion, valid evidence from randomized controlled trials (RCTs) indicates that breast cancer risk is increased with estrogen-progestin use more than with estrogen alone. Epidemiological evidence involving more than 1.5 million women agrees broadly with the trial findings. Although new studies are unlikely to alter the key findings about overall breast cancer risk, research is needed, however, to determine the role of progestin, evaluate the risk of lobular cancer and delineate effects of hormone use on receptor presence, prognosis and mortality in breast cancer. 相似文献
48.
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line 总被引:2,自引:0,他引:2
Wang Y Xue H Cutz JC Bayani J Mawji NR Chen WG Goetz LJ Hayward SW Sadar MD Gilks CB Gout PW Squire JA Cunha GR Wang YZ 《Laboratory investigation; a journal of technical methods and pathology》2005,85(11):1392-1404
Metastasis is the major cause of prostate cancer deaths and there is a need for clinically relevant in vivo models allowing elucidation of molecular and cellular mechanisms underlying metastatic behavior. Here we describe the development of a new in vivo model system for metastatic prostate cancer. Pieces of prostate cancer tissue from a patient were grafted in testosterone-supplemented male NOD-SCID mice at the subrenal capsule graft site permitting high tumor take rates. After five serial transplantations, the tumor tissues were grafted into mouse prostates. Resulting tumors and suspected metastatic lesions were subjected to histopathological and immunohistochemical analysis. Samples of metastatic tissue were regrafted in mouse anterior prostates and their growth and spread examined, leading to isolation from lymph nodes of a metastatic subline, PCa1-met. Orthotopic grafting of PCa1-met tissue in 47 hosts led in all cases to metastases to multiple organs (lymph nodes, lung, liver, kidney, spleen and, notably, bone). Histopathological analysis showed strong similarity between orthotopic grafts and their metastases. The latter were of human origin as indicated by immunostaining using antibodies against human mitochondria, androgen receptor, prostate-specific antigen and Ki-67. Spectral karyotyping showed few chromosomal alterations in the PCa1-met subline. This study indicates that transplantable subrenal capsule xenografts of human prostate cancer tissue in NOD-SCID mice can, as distinct from primary cancer tissue, be successfully grown in the orthotopic site. Orthotopic xenografts of the transplantable tumor lines and metastatic sublines can be used for studying various aspects of metastatic prostate cancer, including metastasis to bone. 相似文献
49.
Jean-Franois Rual Tomoko Hirozane-Kishikawa Tong Hao Nicolas Bertin Siming Li Amlie Dricot Ning Li Jennifer Rosenberg Philippe Lamesch Pierre-Olivier Vidalain Tracey R. Clingingsmith James L. Hartley Dominic Esposito David Cheo Troy Moore Blake Simmons Reynaldo Sequerra Stephanie Bosak Lynn Doucette-Stamm Christian Le Peuch Jean Vandenhaute Michael E. Cusick Joanna S. Albala David E. Hill Marc Vidal 《Genome research》2004,14(10B):2128-2135
The advent of systems biology necessitates the cloning of nearly entire sets of protein-encoding open reading frames (ORFs), or ORFeomes, to allow functional studies of the corresponding proteomes. Here, we describe the generation of a first version of the human ORFeome using a newly improved Gateway recombinational cloning approach. Using the Mammalian Gene Collection (MGC) resource as a starting point, we report the successful cloning of 8076 human ORFs, representing at least 7263 human genes, as mini-pools of PCR-amplified products. These were assembled into the human ORFeome version 1.1 (hORFeome v1.1) collection. After assessing the overall quality of this version, we describe the use of hORFeome v1.1 for heterologous protein expression in two different expression systems at proteome scale. The hORFeome v1.1 represents a central resource for the cloning of large sets of human ORFs in various settings for functional proteomics of many types, and will serve as the foundation for subsequent improved versions of the human ORFeome. 相似文献
50.
Isolation of nontoxigenic Vibrio cholerae O group 1 from a patient with severe gastrointestinal disease. 总被引:6,自引:1,他引:6
下载免费PDF全文
![点击此处可从《Journal of clinical microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
J G Morris Jr J L Picardi S Lieb J V Lee A Roberts M Hood R A Gunn P A Blake 《Journal of clinical microbiology》1984,19(2):296-297
A nontoxigenic strain of Vibrio cholerae O group 1 was isolated in Florida from the stool of a patient with severe diarrhea. The strain had the same hemolytic and unique phage-sensitivity pattern as all toxigenic isolates from recent cases of cholera in Texas and Louisiana. Identical strains were transiently isolated from sewerage systems in two other Florida communities, suggesting that multiple human infections had occurred. This is the first indication that V. cholerae O1 strains which do not produce cholera toxin may be able to cause gastrointestinal disease in humans. The identification of these strains also raises questions about the relationship between toxigenic and nontoxigenic strains of V. cholerae O1 along the Gulf Coast of the United States. 相似文献